THE TGA has approved iNova's ReTrieve Cream (tretinoin 0.05%) for the treatment of acne vulgaris in patients aged 12 and over.
Currently used as an adjunctive therapy for dry, photoaged skin and related conditions, the topical retinoid targets multiple pathogenic factors of acne, including abnormal keratinisation and inflammation.
"Topical retinoids such as tretinoin are widely used in acne care because of their recognised mechanism of action, including beneficial effects on follicular keratinisation and inflammation," said dermatologist Dr Jo-Ann See.
"The availability of an additional approved formulation now provides clinicians with another option to consider where suitable."
The above article was sent to subscribers in Pharmacy Daily's issue from 20 Feb 26
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Feb 26
